Exploration of α1-Antitrypsin Treatment Protocol for Islet Transplantation: Dosing Plan and Route of Administration
Boris M. Baranovski(Ben-Gurion University of the Negev), Eli C. Lewis(Ben-Gurion University of the Negev), Eran Schenker(Ben-Gurion University of the Negev), Ronen Schuster(Ben-Gurion University of the Negev), Nofar Bahar(Ben-Gurion University of the Negev), Omer Nisim(Ben-Gurion University of the Negev), Noa Kalay(Ben-Gurion University of the Negev), Pnina Strauss(Ben-Gurion University of the Negev), Galit Shahaf(Ben-Gurion University of the Negev), David E. Ochayon(Cincinnati Children's Hospital Medical Center), Eyal Ozeri(Ben-Gurion University of the Negev), Mark Mizrahi(Ben-Gurion University of the Negev), Pablo de la Cal(Ben-Gurion University of the Negev)
Cited by 14
Related Papers
Characterization of Transcriptional Regulatory Networks that Promote and Restrict Identities and Functions of Intestinal Innate Lymphoid Cells
|Immunity|2019|94
Acute-phase protein α1-anti-trypsin: diverting injurious innate and adaptive immune responses from non-authentic threats
|Clinical & Experimental Immunology|2014|90
α-1-Antitrypsin Gene Delivery Reduces Inflammation, Increases T-Regulatory Cell Population Size and Prevents Islet Allograft Rejection
|Molecular Medicine|2011|65
Acute Phase Protein α1-Antitrypsin Reduces the Bacterial Burden in Mice by Selective Modulation of Innate Cell Responses
|The Journal of Infectious Diseases|2014|62
IL-33 promotes type 1 cytokine expression via p38 MAPK in human NK cells
|Journal of Leukocyte Biology|2020|51